Teva’s Ambitious Climate Targets Externally Validated by the Science Based Targets initiative (SBTi)

TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its targets to reduce greenhouse gas (GHG) emissions have been approved by the Science Based Targets initiative (SBTi), providing external validation of the Company’s ambitious commitments to minimize its environmental footprint. As one of the world’s largest manufacturers of generic medicines, Teva makes treatments more affordable and accessible – reaching nearly 200 million patien

Leave a Reply

Your email address will not be published. Required fields are marked *